All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Not reported Terminated | 2010-022297-14 | Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurence of Renal Events (BEACON) Valutazione del bardoxolone metile in pazienti con insufficienza r... | 2012-12-19 | due-trials |
| Reported results | 2014-003501-15 | A PHASE 2 STUDY OF THE SAFETY, EFFICACY, AND PHARMACODYNAMICS OF RTA 408 IN THE TREATMENT OF MITOCHONDRIAL MYOPATHY | 2017-11-30 | due-trials |
| Other | 2015-002762-23 | A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia Studio di sicurezza, efficacia e farmacodinamica di fase II di RTA 408 nel trattamen... | not-yet-due | |
| Reported results | 2016-000196-24 | A STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION | 2020-05-07 | due-trials |
| Reported results | 2016-004365-16 | An extended Access Program to Assess Long-Term Safety of Bardoxolone Methyl in Patients with Pulmonary Hypertension | 2020-10-09 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2016-004395-22 | A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome | 2020-10-30 | bad-data |
| Reported results | 2016-004793-17 | A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients with Pulmonary Hypertension | 2018-08-13 | due-trials |
| Completed, reported early | 2018-003253-24 | An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients with Chronic Kidney Disease | 2023-08-23 | not-yet-due |
| Listed as ongoing, but also has a completion date | 2018-004651-20 | A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease | 2023-08-08 | bad-data |